China Medical Technologies Reports Second Fiscal Quarter Financial Results
BEIJING, Nov. 18, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, announced its unaudited financial results for the second fiscal quarter ended September 30, 2011 ("2Q FY2011") today. 2Q FY2011 and Six Months Ended September 30, 2011 Highlights For the Three Months Ended September 30,2010 September 30,2011 September 30,2011 RMB RMB US$ % change (in thousands except for per ADS information) Net revenues 201,834 238,450 37,386 18.1% Net income (loss) (2,936) 33,343 5,228 n/a Diluted earnings (loss) per ADS* (0.11) 1.26 0.20 n/a Non-GAAP net income 65,401 89,557 14,042 36.9% Non-GAAP diluted ea ...

Global Sources reports third quarter 2011 results
NEW YORK, Nov. 17, 2011 /PRNewswire-Asia/ -- Global Sources Ltd. (NASDAQ: GSOL) reported financial results for the third quarter ended September 30, 2011. (Logo: ) "We had a solid quarter, driven by 22% growth in our online business and 17% growth in exhibitions revenue," said Global Sources' executive chairman, Merle A.

LianDi Clean Technology Inc. Reports Financial Results for Second Quarter of Fiscal Year 2012
BEIJING, Nov. 16, 2011 /PRNewswire-Asia/ -- Q2 Software and technical service revenue increased 405% to $5.7 millionGross margin excluding Anhui Jucheng Fine Chemicals Co., Ltd. ("Anhui Jucheng") increased to 36% and 39% for Q2 and the first half of FY 2012, respectivelyBacklog of $50.95 million on September 30, 2011 and an additional backlog of $11.63 million confirmed as of November 15, 2011Anhui Jucheng consummated a private placement transaction in August 2011 with six independent Chinese third party investors and raised approximately $22.23 million in the aggregate for the expansion of its manufacturing facilities and production capabilities, including a new production line for DAC, which is expected to have significant growth potent ...